An interventional study of Echocardiographic and sleep apnea test in Sleep Apnea, sponsored by Zisis Dimitriadis. Completed at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2017-03-23.
Sponsored by Zisis Dimitriadis · Not applicable, Interventional, and Diagnostic
The investigators evaluate the changes of echocardiographic and sleep apnea parameters after mitral valve surgery. The patients undergo echocardiographic and sleep apnea control before surgery. After a period of 3-5 months, they undergo a second echocardiographic and sleep apnea control and the results are evaluated.
1,422 studies on the registry are indexed under Apnea; 159 are open to participants now.
This study's enrollment of 132 is above the median of 50 across 965 interventional studies indexed under Apnea.
Browse Apnea studies →This is the only study on the registry with Zisis Dimitriadis as lead sponsor.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Echocardiographic Evaluation of systolic and diastolic function of both ventricles and evaluation of apnea-hypopnea index and type of apnea
Procedure: Echocardiographic and sleep apnea test
Echocardiographic evaluation (Vivid 7, GE) of systolic and diastolic function of both ventricles as well as evaluation of apnea-hypopnea index and type of apnea (ApneaLink®)
Changes of left ventricular systolic function
Time frame: 1-4 weeks before and 3 months after surgery
Changes of apnea-hypopnea index
Time frame: 1-4 weeks before and 3 months after surgery
Changes of global longitudinal strain
Time frame: 1-4 weeks before and 3 months after surgery
Changes of right ventricular systolic function
Time frame: 1-4 weeks before and 3 months after surgery
This study is completed, as verified in Mar 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.